The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Eribulin plus trastuzumab in pretreated HER2-positive advanced breast cancer (ABC) patients: Results on safety and efficacy—An Italian multicenter experience.
 
Stefania Eufemia Lutrino
No Relationships to Disclose
 
Laura Orlando
No Relationships to Disclose
 
Caterina Fontanella
No Relationships to Disclose
 
Antonio Febbraro
No Relationships to Disclose
 
Marianna Giampaglia
No Relationships to Disclose
 
Claudio Zamagni
Consulting or Advisory Role - Fresenius Biotech; Genomic Health; Pierre Fabre; Roche
Travel, Accommodations, Expenses - Celgene; Ipsen; Novartis; Roche
 
Claudio Scavelli
No Relationships to Disclose
 
Guido Giordano
No Relationships to Disclose
 
Enrico Basso
No Relationships to Disclose
 
Sara Quercia
No Relationships to Disclose
 
Annamaria Quaranta
No Relationships to Disclose
 
Claudia Corbo
No Relationships to Disclose
 
Rosangela Romano
No Relationships to Disclose
 
Daniela Rubino
No Relationships to Disclose
 
Chiara Caliolo
No Relationships to Disclose
 
Serena Campidoglio
No Relationships to Disclose
 
Domenico Bilancia
No Relationships to Disclose
 
Elena Barbieri
No Relationships to Disclose
 
Antonella Marino
No Relationships to Disclose
 
Saverio Cinieri
No Relationships to Disclose